Sequential Therapies After Osteoanabolic Treatment

Conditions: Osteoporosis, Postmenopausal Interventions: Drug: Zoledronate; Drug: Denosumab; Drug: Teriparatide; Drug: Romosozumab Sponsors: 424 General Military Hospital Recruiting

https://clinicaltrials.gov/study/NCT06164795

Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials